Serveur d'exploration MERS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

A systematic review of MERS-CoV seroprevalence and RNA prevalence in dromedary camels: Implications for animal vaccination.

Identifieur interne : 000687 ( PubMed/Checkpoint ); précédent : 000686; suivant : 000688

A systematic review of MERS-CoV seroprevalence and RNA prevalence in dromedary camels: Implications for animal vaccination.

Auteurs : Amy Dighe [Royaume-Uni] ; Thibaut Jombart [Royaume-Uni] ; Maria D. Van Kerkhove [Suisse] ; Neil Ferguson [Royaume-Uni]

Source :

RBID : pubmed:31201040

Abstract

Human infection with Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is driven by recurring dromedary-to-human spill-over events, leading decision-makers to consider dromedary vaccination. Dromedary vaccine candidates in the development pipeline are showing hopeful results, but gaps in our understanding of the epidemiology of MERS-CoV in dromedaries must be addressed to design and evaluate potential vaccination strategies. We aim to bring together existing measures of MERS-CoV infection in dromedary camels to assess the distribution of infection, highlighting knowledge gaps and implications for animal vaccination. We systematically reviewed the published literature on MEDLINE, EMBASE and Web of Science that reported seroprevalence and/or prevalence of active MERS-CoV infection in dromedary camels from both cross-sectional and longitudinal studies. 60 studies met our eligibility criteria. Qualitative syntheses determined that MERS-CoV seroprevalence increased with age up to 80-100% in adult dromedaries supporting geographically widespread endemicity of MERS-CoV in dromedaries in both the Arabian Peninsula and countries exporting dromedaries from Africa. The high prevalence of active infection measured in juveniles and at sites where dromedary populations mix should guide further investigation - particularly of dromedary movement - and inform vaccination strategy design and evaluation through mathematical modelling.

DOI: 10.1016/j.epidem.2019.100350
PubMed: 31201040


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:31201040

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">A systematic review of MERS-CoV seroprevalence and RNA prevalence in dromedary camels: Implications for animal vaccination.</title>
<author>
<name sortKey="Dighe, Amy" sort="Dighe, Amy" uniqKey="Dighe A" first="Amy" last="Dighe">Amy Dighe</name>
<affiliation wicri:level="1">
<nlm:affiliation>MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, Medical School Building, St Mary's Hospital, Norfolk Place, London, W2 1PG, United Kingdom. Electronic address: a.dighe16@imperial.ac.uk.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, Medical School Building, St Mary's Hospital, Norfolk Place, London, W2 1PG</wicri:regionArea>
<wicri:noRegion>W2 1PG</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Jombart, Thibaut" sort="Jombart, Thibaut" uniqKey="Jombart T" first="Thibaut" last="Jombart">Thibaut Jombart</name>
<affiliation wicri:level="1">
<nlm:affiliation>MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, Medical School Building, St Mary's Hospital, Norfolk Place, London, W2 1PG, United Kingdom; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, Keppel St, Bloomsbury, London, WC1E 7HT, United Kingdom; UK Public Health Rapid Support Team, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, United Kingdom. Electronic address: thibautjombart@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, Medical School Building, St Mary's Hospital, Norfolk Place, London, W2 1PG, United Kingdom; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, Keppel St, Bloomsbury, London, WC1E 7HT, United Kingdom; UK Public Health Rapid Support Team, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT</wicri:regionArea>
<wicri:noRegion>WC1E 7HT</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Van Kerkhove, Maria D" sort="Van Kerkhove, Maria D" uniqKey="Van Kerkhove M" first="Maria D" last="Van Kerkhove">Maria D. Van Kerkhove</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Global Infectious Hazards Management, Health Emergencies Program, World Health Organization, Avenue Appia 20, CH-1211, Geneva, Switzerland. Electronic address: vankerkhovem@who.int.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Global Infectious Hazards Management, Health Emergencies Program, World Health Organization, Avenue Appia 20, CH-1211, Geneva</wicri:regionArea>
<wicri:noRegion>Geneva</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ferguson, Neil" sort="Ferguson, Neil" uniqKey="Ferguson N" first="Neil" last="Ferguson">Neil Ferguson</name>
<affiliation wicri:level="1">
<nlm:affiliation>MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, Medical School Building, St Mary's Hospital, Norfolk Place, London, W2 1PG, United Kingdom. Electronic address: neil.ferguson@imperial.ac.uk.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, Medical School Building, St Mary's Hospital, Norfolk Place, London, W2 1PG</wicri:regionArea>
<wicri:noRegion>W2 1PG</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:31201040</idno>
<idno type="pmid">31201040</idno>
<idno type="doi">10.1016/j.epidem.2019.100350</idno>
<idno type="wicri:Area/PubMed/Corpus">000505</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000505</idno>
<idno type="wicri:Area/PubMed/Curation">000505</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000505</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000687</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000687</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">A systematic review of MERS-CoV seroprevalence and RNA prevalence in dromedary camels: Implications for animal vaccination.</title>
<author>
<name sortKey="Dighe, Amy" sort="Dighe, Amy" uniqKey="Dighe A" first="Amy" last="Dighe">Amy Dighe</name>
<affiliation wicri:level="1">
<nlm:affiliation>MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, Medical School Building, St Mary's Hospital, Norfolk Place, London, W2 1PG, United Kingdom. Electronic address: a.dighe16@imperial.ac.uk.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, Medical School Building, St Mary's Hospital, Norfolk Place, London, W2 1PG</wicri:regionArea>
<wicri:noRegion>W2 1PG</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Jombart, Thibaut" sort="Jombart, Thibaut" uniqKey="Jombart T" first="Thibaut" last="Jombart">Thibaut Jombart</name>
<affiliation wicri:level="1">
<nlm:affiliation>MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, Medical School Building, St Mary's Hospital, Norfolk Place, London, W2 1PG, United Kingdom; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, Keppel St, Bloomsbury, London, WC1E 7HT, United Kingdom; UK Public Health Rapid Support Team, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, United Kingdom. Electronic address: thibautjombart@gmail.com.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, Medical School Building, St Mary's Hospital, Norfolk Place, London, W2 1PG, United Kingdom; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, Keppel St, Bloomsbury, London, WC1E 7HT, United Kingdom; UK Public Health Rapid Support Team, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT</wicri:regionArea>
<wicri:noRegion>WC1E 7HT</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Van Kerkhove, Maria D" sort="Van Kerkhove, Maria D" uniqKey="Van Kerkhove M" first="Maria D" last="Van Kerkhove">Maria D. Van Kerkhove</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Global Infectious Hazards Management, Health Emergencies Program, World Health Organization, Avenue Appia 20, CH-1211, Geneva, Switzerland. Electronic address: vankerkhovem@who.int.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Department of Global Infectious Hazards Management, Health Emergencies Program, World Health Organization, Avenue Appia 20, CH-1211, Geneva</wicri:regionArea>
<wicri:noRegion>Geneva</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ferguson, Neil" sort="Ferguson, Neil" uniqKey="Ferguson N" first="Neil" last="Ferguson">Neil Ferguson</name>
<affiliation wicri:level="1">
<nlm:affiliation>MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, Medical School Building, St Mary's Hospital, Norfolk Place, London, W2 1PG, United Kingdom. Electronic address: neil.ferguson@imperial.ac.uk.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, Medical School Building, St Mary's Hospital, Norfolk Place, London, W2 1PG</wicri:regionArea>
<wicri:noRegion>W2 1PG</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Epidemics</title>
<idno type="eISSN">1878-0067</idno>
<imprint>
<date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Human infection with Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is driven by recurring dromedary-to-human spill-over events, leading decision-makers to consider dromedary vaccination. Dromedary vaccine candidates in the development pipeline are showing hopeful results, but gaps in our understanding of the epidemiology of MERS-CoV in dromedaries must be addressed to design and evaluate potential vaccination strategies. We aim to bring together existing measures of MERS-CoV infection in dromedary camels to assess the distribution of infection, highlighting knowledge gaps and implications for animal vaccination. We systematically reviewed the published literature on MEDLINE, EMBASE and Web of Science that reported seroprevalence and/or prevalence of active MERS-CoV infection in dromedary camels from both cross-sectional and longitudinal studies. 60 studies met our eligibility criteria. Qualitative syntheses determined that MERS-CoV seroprevalence increased with age up to 80-100% in adult dromedaries supporting geographically widespread endemicity of MERS-CoV in dromedaries in both the Arabian Peninsula and countries exporting dromedaries from Africa. The high prevalence of active infection measured in juveniles and at sites where dromedary populations mix should guide further investigation - particularly of dromedary movement - and inform vaccination strategy design and evaluation through mathematical modelling.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="In-Process" Owner="NLM">
<PMID Version="1">31201040</PMID>
<DateRevised>
<Year>2020</Year>
<Month>03</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1878-0067</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>29</Volume>
<PubDate>
<Year>2019</Year>
<Month>12</Month>
</PubDate>
</JournalIssue>
<Title>Epidemics</Title>
<ISOAbbreviation>Epidemics</ISOAbbreviation>
</Journal>
<ArticleTitle>A systematic review of MERS-CoV seroprevalence and RNA prevalence in dromedary camels: Implications for animal vaccination.</ArticleTitle>
<Pagination>
<MedlinePgn>100350</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S1755-4365(19)30041-6</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.epidem.2019.100350</ELocationID>
<Abstract>
<AbstractText>Human infection with Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is driven by recurring dromedary-to-human spill-over events, leading decision-makers to consider dromedary vaccination. Dromedary vaccine candidates in the development pipeline are showing hopeful results, but gaps in our understanding of the epidemiology of MERS-CoV in dromedaries must be addressed to design and evaluate potential vaccination strategies. We aim to bring together existing measures of MERS-CoV infection in dromedary camels to assess the distribution of infection, highlighting knowledge gaps and implications for animal vaccination. We systematically reviewed the published literature on MEDLINE, EMBASE and Web of Science that reported seroprevalence and/or prevalence of active MERS-CoV infection in dromedary camels from both cross-sectional and longitudinal studies. 60 studies met our eligibility criteria. Qualitative syntheses determined that MERS-CoV seroprevalence increased with age up to 80-100% in adult dromedaries supporting geographically widespread endemicity of MERS-CoV in dromedaries in both the Arabian Peninsula and countries exporting dromedaries from Africa. The high prevalence of active infection measured in juveniles and at sites where dromedary populations mix should guide further investigation - particularly of dromedary movement - and inform vaccination strategy design and evaluation through mathematical modelling.</AbstractText>
<CopyrightInformation>Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Dighe</LastName>
<ForeName>Amy</ForeName>
<Initials>A</Initials>
<AffiliationInfo>
<Affiliation>MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, Medical School Building, St Mary's Hospital, Norfolk Place, London, W2 1PG, United Kingdom. Electronic address: a.dighe16@imperial.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Jombart</LastName>
<ForeName>Thibaut</ForeName>
<Initials>T</Initials>
<AffiliationInfo>
<Affiliation>MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, Medical School Building, St Mary's Hospital, Norfolk Place, London, W2 1PG, United Kingdom; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, Keppel St, Bloomsbury, London, WC1E 7HT, United Kingdom; UK Public Health Rapid Support Team, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, United Kingdom. Electronic address: thibautjombart@gmail.com.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Van Kerkhove</LastName>
<ForeName>Maria D</ForeName>
<Initials>MD</Initials>
<AffiliationInfo>
<Affiliation>Department of Global Infectious Hazards Management, Health Emergencies Program, World Health Organization, Avenue Appia 20, CH-1211, Geneva, Switzerland. Electronic address: vankerkhovem@who.int.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Ferguson</LastName>
<ForeName>Neil</ForeName>
<Initials>N</Initials>
<AffiliationInfo>
<Affiliation>MRC Centre for Global Infectious Disease Analysis, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, Medical School Building, St Mary's Hospital, Norfolk Place, London, W2 1PG, United Kingdom. Electronic address: neil.ferguson@imperial.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>001</GrantID>
<Acronym>WHO_</Acronym>
<Agency>World Health Organization</Agency>
<Country>International</Country>
</Grant>
<Grant>
<GrantID>MR/R015600/1</GrantID>
<Acronym>MRC_</Acronym>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2019</Year>
<Month>06</Month>
<Day>05</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>Netherlands</Country>
<MedlineTA>Epidemics</MedlineTA>
<NlmUniqueID>101484711</NlmUniqueID>
<ISSNLinking>1878-0067</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="Y">Dromedary camels</Keyword>
<Keyword MajorTopicYN="Y">MERS-CoV</Keyword>
<Keyword MajorTopicYN="Y">Prevalence of infection</Keyword>
<Keyword MajorTopicYN="Y">Seroprevalence</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2019</Year>
<Month>03</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2019</Year>
<Month>05</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2019</Year>
<Month>06</Month>
<Day>03</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2019</Year>
<Month>6</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2019</Year>
<Month>6</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2019</Year>
<Month>6</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">31201040</ArticleId>
<ArticleId IdType="pii">S1755-4365(19)30041-6</ArticleId>
<ArticleId IdType="doi">10.1016/j.epidem.2019.100350</ArticleId>
<ArticleId IdType="pmc">PMC6899506</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>J Virol Methods. 2018 Jan;251:22-29</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28993122</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Microbes Infect. 2017 Jun 21;6(6):e56</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28634355</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2017 Sep 13;12(9):e0184718</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28902913</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Microbes Infect. 2015 Dec 02;4(12):e73</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26632875</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Infect Ecol Epidemiol. 2015 Jul 15;5:28305</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26183160</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virol Sin. 2018 Dec;33(6):484-492</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30570714</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Microbes Infect. 2018 Nov 28;7(1):195</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30482895</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Euro Surveill. 2014 Jun 12;19(23):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24957745</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet Infect Dis. 2013 Oct;13(10):859-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23933067</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virus Genes. 2016 Dec;52(6):848-854</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27357298</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2014 Aug;20(8):1339-42</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25075761</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2014 Jul;20(7):1231-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24964193</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Rev Sci Tech. 2009 Apr;28(1):359-69</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19618639</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2014 Aug;20(8):1319-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25075637</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Euro Surveill. 2015;20(49):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26676406</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>PLoS One. 2015 Oct 16;10(10):e0140125</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26473733</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2014 Jun;20(6):1049-53</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24856660</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2015 Jul;21(7):1153-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26079346</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Euro Surveill. 2015;20(37):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26536463</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Trop Anim Health Prod. 2018 Jun;50(5):1155-1160</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29450815</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet Infect Dis. 2014 Feb;14(2):140-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24355866</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2014 Apr;20(4):552-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24655412</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Vaccine. 2017 Jun 27;35(30):3780-3788</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28579232</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2013 Oct;100(1):8-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23838047</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2012 Nov 8;367(19):1814-20</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23075143</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Zoonoses Public Health. 2018 May;65(3):322-333</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29239118</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>One Health. 2017 Mar 10;3:41-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28616502</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2013 Aug 24;382(9893):694-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23831141</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Am J Trop Med Hyg. 2017 Jun;96(6):1318-1324</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28719257</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Jpn J Infect Dis. 2015;68(3):256-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25993975</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Euro Surveill. 2018 Aug;23(32):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30107872</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Euro Surveill. 2014 Apr 24;19(16):20781</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24786259</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2014 Aug;20(8):1370-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25062254</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Vaccine. 2017 Mar 23;35(13):1668-1674</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28216188</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2015 Jun;21(6):1019-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25989145</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Trop Anim Health Prod. 2016 Aug;48(6):1277-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27324244</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Vector Borne Zoonotic Dis. 2017 Feb;17(2):155-159</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28009529</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect Public Health. 2018 May - Jun;11(3):331-338</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28993171</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Vaccine. 2009 Jun 2;27(27):3655-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19464547</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Science. 2016 Jan 1;351(6268):81-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26678874</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>One Health. 2015 Nov 02;1:76-82</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28616468</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Zoonoses Public Health. 2018 Sep;65(6):749-754</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29855166</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Euro Surveill. 2013 Dec 12;18(50):20662</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24342516</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Euro Surveill. 2013 Jun 13;18(24):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23787162</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2015 Dec;21(12):2197-200</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26584223</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Sci Rep. 2016 Jul 12;6:29463</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27405887</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virus Genes. 2015 Jun;50(3):509-13</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25653016</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Microbes Infect. 2017 Nov 8;6(11):e101</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29116217</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2017 Mar;23(3):550-551</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28221127</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Virol Sin. 2018 Oct;33(5):410-417</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30311100</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Trop Anim Health Prod. 2010 Aug;42(6):1087-92</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20195755</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2014 Dec;20(12):1999-2005</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25418529</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2018 May;24(5):926-928</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29664373</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Transbound Emerg Dis. 2014 Apr;61(2):105-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24456414</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>mBio. 2014 Feb 25;5(2):e00884-14</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24570370</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>One Health. 2018 May 04;5:65-68</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29911167</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Epidemiol Infect. 2019 Jan;147:e84</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30869000</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2015 Jul;21(7):1269-71</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26080032</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Vaccine. 2013 Nov 4;31(46):5321-38</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24060567</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Rev Sci Tech. 2016 Dec;35(3):905-911</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28332641</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Med Virol. 2018 Aug;90(8):1285-1289</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29663439</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Infect Public Health. 2018 Nov - Dec;11(6):884-888</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29396257</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Euro Surveill. 2017 Mar 30;22(13):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28382915</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Euro Surveill. 2017 Mar 16;22(11):</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28333616</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Transbound Emerg Dis. 2017 Apr;64(2):344-353</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26256102</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Microbes Infect. 2017 Jan 4;6(1):e1</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28050021</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Nat Commun. 2014 Jun 17;5:4116</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24937647</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Euro Surveill. 2014 Jun 12;19(23):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24957744</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Euro Surveill. 2012 Sep 27;17(39):null</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23041020</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2016 Dec;22(12):2171-2173</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27224315</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2014 Jun 26;370(26):2499-505</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24896817</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Travel Med Infect Dis. 2019 Jan - Feb;27:125-126</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30218713</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2014 Dec;20(12):2093-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25425139</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Science. 2016 Jan 1;351(6268):77-81</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26678878</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2016 Mar;22(3):555-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26889787</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Euro Surveill. 2013 Dec 12;18(50):20659</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24342517</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2014 Jun;20(6):1012-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24857749</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Antiviral Res. 2018 Nov;159:35-44</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30236531</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Microbes Infect. 2015 Dec 02;4(12):e74</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">26632876</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>BMC Infect Dis. 2019 Feb 4;19(1):113</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30717685</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Euro Surveill. 2013 Sep 05;18(36):pii=20574</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24079378</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):3144-3149</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29507189</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Royaume-Uni</li>
<li>Suisse</li>
</country>
</list>
<tree>
<country name="Royaume-Uni">
<noRegion>
<name sortKey="Dighe, Amy" sort="Dighe, Amy" uniqKey="Dighe A" first="Amy" last="Dighe">Amy Dighe</name>
</noRegion>
<name sortKey="Ferguson, Neil" sort="Ferguson, Neil" uniqKey="Ferguson N" first="Neil" last="Ferguson">Neil Ferguson</name>
<name sortKey="Jombart, Thibaut" sort="Jombart, Thibaut" uniqKey="Jombart T" first="Thibaut" last="Jombart">Thibaut Jombart</name>
</country>
<country name="Suisse">
<noRegion>
<name sortKey="Van Kerkhove, Maria D" sort="Van Kerkhove, Maria D" uniqKey="Van Kerkhove M" first="Maria D" last="Van Kerkhove">Maria D. Van Kerkhove</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000687 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000687 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    MersV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:31201040
   |texte=   A systematic review of MERS-CoV seroprevalence and RNA prevalence in dromedary camels: Implications for animal vaccination.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:31201040" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a MersV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Mon Apr 20 23:26:43 2020. Site generation: Sat Mar 27 09:06:09 2021